Retrophin President and Chief Executive Officer Eric Dube Named to the 2020 PharmaVOICE 100

SAN DIEGO (August 3, 2020) – Retrophin,  Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., president  and chief  executive officer, has been named by PharmaVOICE magazine to the 2020 PharmaVOICE 100 – an award that recognizes the 100 Most Inspiring People in the life sciences industry. Read the press release >